William E. Martin III - 17 Oct 2022 Form 4 Insider Report for MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI)

Role
Officer
Signature
/s/ Kurt Oreshack, by power of attorney for William E. Martin, III
Issuer symbol
MRVI
Transactions as of
17 Oct 2022
Net transactions value
$0
Form type
4
Filing time
19 Oct 2022, 16:39:09 UTC
Previous filing
05 Oct 2022
Next filing
22 Aug 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRVI Class A Common Stock Award +120,019 120,019 17 Oct 2022 Direct F1
transaction MRVI Class A Common Stock Award +228,036 +190% 348,055 17 Oct 2022 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRVI Employee Stock Option (Right to Buy) Award $0 +403,946 $0.000000 403,946 17 Oct 2022 Class A Common Stock 403,946 $19.42 Direct F3
transaction MRVI Performance Stock Units Award $0 +240,038 $0.000000 240,038 17 Oct 2022 Class A Common Stock 240,038 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units ("RSUs") awarded under the Maravai LifeSciences Holdings, Inc. 2020 Omnibus Incentive Plan (the "Omnibus Incentive Plan"). Each RSU represents the right to receive one share of Class A Common Stock of the Issuer upon vesting, subject to the Reporting Person's continued employment with the Issuer. The RSUs will vest 50% on each of October 17, 2023 and October 17, 2024, subject to the Reporting Person's continued employment with the Issuer.
F2 Represents RSUs awarded under the Omnibus Incentive Plan. Each RSU represents the right to receive one share of Class A Common Stock of the Issuer upon vesting, subject to the Reporting Person's continued employment with the Issuer. The RSUs will vest in 1/3rd increments on each of October 17, 2023, October 17, 2024, and October 17, 2025, subject to the Reporting Person's continued employment with the Issuer.
F3 Represents options awarded under the Omnibus Incentive Plan. These options will vest 25% on October 17, 2023 and in near-equal 1/36th installments each month thereafter, subject to the Reporting Person's continued employment with the Issuer.
F4 Represents performance stock units ("PSUs") awarded under the Omnibus Incentive Plan. Each PSU represents the contingent right to receive one share of Class A Common Stock of the Issuer. The PSUs will vest on October 17, 2025, if and to the extent the 60-trading day volume-weighted average stock price of the Class A Common Stock of the Issuer equals or exceeds certain thresholds, provided that in the event of a Change in Control (as defined in the Omnibus Incentive Plan) prior to October 17, 2025, the PSUs will convert to time-based RSUs that will fully vest on October 17, 2025, subject to the Reporting Person's continued employment with the Issuer.

Remarks:

The Reporting Person was performing the responsibilities of Chief Executive Officer of the Company on October 17, 2022. Effective October 18, 2022, the Reporting Person commenced a temporary leave of absence, and during his leave of absence, the Reporting Person is not expected to perform any responsibilities as Chief Executive Officer of the Company.